CClinicalTrials.gg
CompletedNCT05073445ResiStressUpdated Mar 18, 2022

Stress and Resilience in Anesthesia Professionals

An observational study in Stress, Professional, Resilience and Anaesthesiology, sponsored by University Hospital, Grenoble. Completed at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-18.

Sponsored by University Hospital, Grenoble · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
34
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study was to analyze the correlation between the resilience of anesthesia professionals and the stress measured during a simulation session.

Read the detailed description

This trial will be carried out at the simulation center of the training institute for health professionals of the CHU Grenoble Alpes. Volunteer anesthesia professionals and students will perform a scenario simulating a pediatric laryngospasm during a surgical incision.

Each scenario will be performed by a medical and paramedical anesthesia pair and supervised by simulation trainers.

Stress and resilience measures will be taken at various times during the study. Participants will be debriefed at the end of the simulation.

The primary objective is to analyze the correlation between anesthesia professionals' resilience and measured stress.Secondary objectives are to study the association between: SDNN-measured stress and VAS-reported stress, age and SDNN-measured stress, CD RISC 10 resilience and PSS10-reported stress, CD RISC resilience and VAS-reported stress, the effect of experience on SDNN-measured stress, multiple correlation of the different secondary criteria.

secondary criteria.

02

Conditions studied

  • Stress, Professional
  • Resilience
  • Anaesthesiology
  • High Fidelity Simulation

Browse trials for

03

In context

Occupational Stress

236 studies on the registry are indexed under Occupational Stress; 64 are open to participants now.

This study's enrollment of 34 is below the median of 200 across 64 observational studies indexed under Occupational Stress.

Browse Occupational Stress studies →

Lead sponsor

University Hospital, Grenoble is the lead sponsor of 815 studies on the registry; 205 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Anaesthetic teams composed with :

  • 1 resident in anaesthesiology and critical care OR Anesthesiologist AND
  • 1 anaesthetic nursing student OR 1 anaesthetic nurse graduated

Inclusion criteria

  • volunteer in anesthesia

Exclusion criteria

Exclusion Criteria:

  • Rhythm disorders
  • Endocrine pathology
  • High blood pressure
  • Pregnancy or breastfeeding in progress
  • Taking anti-inflammatory or psychotropic drugs that interfere with the heart rate
  • Interruption of professional practice in anesthesia > 2 years
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
34 participants (actual)
Patient registry
No

Interventions

  • BehavioralSDNN measurement

    SDNN measurement during pediatric simulation

06

What researchers measure

Primary outcomes

  1. Heart rate variability

    Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants

    Time frame: during the laryngospasm (during 3 minutes at 6 minutes)

  2. Resilience

    Measurement of resilience by Connor-Davidson Resilience Scale 10 (CD RISC 10 from 0 to 40) in participants. A high score indicates better resilience.

    Time frame: 5 days before scenario

Secondary outcomes

  1. Self-reported stress

    Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).

    Time frame: 5 days before scenario

  2. Self-reported stress

    Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).

    Time frame: just Before the scenario (at 0 minute )

  3. Self-reported stress

    Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).

    Time frame: just after briefing (at 3 minutes)

  4. Self-reported stress

    Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).

    Time frame: just after the end of scenario (at 9 minutes)

  5. Self-reported stress

    Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).

    Time frame: just after the debriefing (at 30 minutes)

  6. Perceived Stress Scale

    The Perceived Stress Scale (PSS10 from 10 To 50) measures the degree to which respondents feel their lives are unpredictable, uncontrollable, and overloaded. A high score indicates more stress.

    Time frame: 5 days before scenario

  7. Age of anesthesia professionals

    Age of anesthesia professionals: (quantitative variable)

    Time frame: 5 days before scenario

  8. Experience in anesthesia:

    Experience in anesthesia: number of years since the beginning of specialized training training (quantitative variable)

    Time frame: 5 days before scenario

  9. Pediatric experience:

    Pediatric experience: qualitative variable (yes, no)

    Time frame: 5 days before scenario

  10. Pediatric laryngospasm experience

    Pediatric laryngospasm experience: qualitative variable: (yes, no)

    Time frame: 5 days before scenario

  11. Heart rate variability

    Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants

    Time frame: 5 days before scenario (during 3 minutes)

  12. Heart rate variability

    Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants

    Time frame: Before the scenario (during 3 minutes)

  13. Heart rate variability

    Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants

    Time frame: during briefing (during 3 minutes at 0 minutes)

  14. Heart rate variability

    Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants

    Time frame: during the scenario before the laryngospasm (during 3 minutes at 3 minutes)

  15. Heart rate variability

    Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants

    Time frame: during the debriefing (3 minutes at 9 minutes)

  16. Heart rate variability

    Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants

    Time frame: after the debriefing (3 minutes at 30 minutes)

07

Study locations

1 site
  • University Hospital
    Grenoble, 38000, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 18, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05073445
Lead sponsor
University Hospital, Grenoble
Responsible party
Sponsor
First posted
Oct 11, 2021
Start date
Jun 18, 2021
Primary completion
Oct 13, 2021
Completion
Nov 15, 2021
Last update
Mar 18, 2022

Study contacts

Yoann Zafiriou
principal investigator · University Hospital, Grenoble
Julien Picard, M.D, Ph.D.
principal investigator · University Hospital, Grenoble

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion